Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation
Clinical trial NCT03285802 · COMPLETED
Trial details
- NCT number
- NCT03285802
- Sponsor
- Greater Baltimore Medical Center
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-07
- Primary completion
- 2019-02-12
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.